RAP 0.00% 20.5¢ raptor resources limited

Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-209

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 3,464 Posts.
    lightbulb Created with Sketch. 956
    These positive Resapp dx results was mainly a result of SPECIALIST Doctors not agreeing on over 30% of a diagnosis based on test results including a subjective physical examination, micro biology, and WHO standard Xray requirements.

    All that in depth hospital testing including a subjective physical examination took these SPECIALISTS Doctors weeks to disagree on a diagnosis in over 30% of the cases.

    Resapp, produced instant objective results.

    Giving the hospital data to more Doctors to evaluate will present more uncertainty as the element of doctor subjectivity is still present.

    The question is really did the doctors fail the diagnosis test?
    Drs scored 70%
    To my thinking the Doctors failed this Clinical Trial.

    So the real big question is, what can the RAP team do about an established system of Specialist doctor diagnosis practice that is obviously over 30% flawed?

    When a patient gets a diagnosis from one specialist doctor based on all the tests the patients parents usually accept it on the way it is sold by the Specialist Dr and treatment begins.

    Go to another Dr and you may well get in many cases a different diagnosis, in this case on over 1600 patients a different opinion that is now proven to be over 30% inaccurate and that is what sticks out like too many balls on a tennis court.

    What to do now, is about how do you get agreement from drs?
    More won't help.
    Just more balls on the tennis court to deal with.

    All the above is my opinion and thoughts and should not be used to make an investment decision in RAP.

    Happy Bentley
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.